Researchers from the European Centre for Allergy Research Foundation (ECARF) and the Institute of Allergology at Charité Universitätsmedizin Berlin have conducted clinical trials on Respiray Wear A+, revealing that the wearable allergy relief device reduced the symptoms of pollen, dust mite and cat allergies more effectively than most anti-allergy medications or allergen-specific immunotherapy.
Full Article
MONDAY, May 13, 2024 (HealthDay News) -- About a third of young children who are allergic to peanuts will outgrow the allergy by the age of 10, and an antibody test might predict who those kids might be.